Skip to main
CL

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 35%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Colgate-Palmolive is a well-established company in the household and personal care industry, with a global presence and strong brand recognition. Their diverse product portfolio, including oral care, personal care, and home care products, helps mitigate risks in any particular market or category. While facing challenges in the US market, the company continues to demonstrate strong performance in emerging markets, driven by its premiumization strategy. Despite some short-term headwinds in the form of higher input costs and competition, Colgate-Palmolive's solid financial foundation and strategic investments suggest strong potential for long-term growth and value creation for shareholders.

Bears say

Colgate-Palmolive is facing multiple headwinds in the coming year, including potential negative impacts from the exit of a private label pet food business and increased costs due to conflict-related pressure on oil prices. Furthermore, the company's sustainability initiatives and continued long-term growth may be outweighed by these challenges, leading to a negative outlook for the stock.

Colgate-Palmolive (CL) has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 35% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 17 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $97.82, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $97.82, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.